Dr. Fon Tacer has been investigating the function of the MAGEL2 protein and believes it plays an important role in how cells adapt to stress. In this study she will explore how cellular stress responses are altered when MAGEL2 is lost.
Dr. Theresa Strong, Director of Research Programs, shares details on this project in this short video clip.
With the proposed project we aim to get the first insight into the role of PWS-associated gene MAGEL2 in the regulation of the hypothalamus-pituitary-adrenal axis (HPA) in animals under stress. The HPA axis is the master regulator of our body’s stress response that allows for efficient adaptation to acute and chronic changes in the environment, important for normal development and health. Several symptoms, including characteristic behavior, hyperphagia, and autism spectrum disorder, suggest that the adaptation is severely compromised in PWS/SYS patients. In an ever-changing environment, stress response and adaptation to various homeostatic challenges were evolutionary critical for survival. Multiple and overlapping mechanisms evolved to deal with both acute and prolonged threats. Melanoma antigen (MAGE) protein family expanded very recently in evolutionary history from one gene in ancestral eukaryotes to more than forty genes in our genomes. Recent discoveries that several MAGE protein family members which are uniquely expressed in male germs cells evolved because they protect germline and fertility under stressful conditions and provided evolutionary advantage under suboptimal conditions, provided a new view of the physiological role of these proteins. In this proposal, we aim to investigate whether MAGEL2, too, provides benefit under stress and faster adaptation to homeostatic challenges. MAGEL2 is a gene frequently deleted or mutated in individuals affected with PWS and SYS. Furthermore, mice lacking MAGEL2 display symptoms similar to those seen in PWS/SYS children. We have previously shown that MAGE-L2 functions to prevent aberrant degradation of specific proteins that normally reside in the plasma membrane or are secreted by the hypothalamus, including several neuropeptides. Here, we will investigate the role of MAGEL2 in the hypothalamus, pituitary, and adrenal, where MAGEL2 is expressed, in animals that encounter stress. We will perform analysis by single-cell and in situ gene expression analysis, determining MAGEL2 binding partners under stress, and investigating MAGEL2 role in specialized translation, one of the major cellular mechanisms to cope with stress in the central nervous system. We expect that the results of the proposed studies will provide completely novel insight into MAGEL2 molecular function in the hope of discovering better therapeutic avenues to help children and adults with PWS and SYS.
Klementina Fon Tacer, DVM, Ph.D.
Texas Tech University
Klementina Fon Tacer, DVM, PhD